IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    SCOTUS takes Trump's Jan. 6 case, delaying Jack Smith's DOJ trial: Melber report

    11:49
  • 'Fraud': Indicted Trump may lose again -- unless ‘political burnout’ curbs turnout

    09:24
  • 'God Save Texas' trilogy shows the complexity of the state

    07:36
  • 'There is no link to Joe Biden': House Dem slams GOP impeachment inquiry

    05:15
  • 'American Woman' looks at first ladies from Clinton to Biden

    07:18
  • 'Really creepy': Former Australian PM on Trump's admiration for Putin

    06:09
  • 'It would be a disaster for everyone': Should Biden debate Trump? 

    11:11
  • Sen. Manchin says term limits the key to 'performance' in Congress

    12:40
  • What brought more than 100,000 to cast 'uncommitted' votes in Michigan

    03:48
  • 100K+ Michiganders vote for 'uncommitted' over Biden

    04:14
  • 'These aren't good numbers': Warning signs emerge for Trump after Michigan

    04:55
  • Joe: If there was a time in Michigan to send a message to Biden, this was it

    03:48
  • Steve Kornacki: What drove Trump's win, Haley's slipping in Michigan

    04:16
  • McQuade: Trump’s election lies create danger to the rule of law

    06:23
  • Michigan Dem: Contrast between Biden and Trump ‘could not be clearer’

    04:58
  • Joe Biden wins the Michigan Democratic primary

    08:07
  • Biden hopes to bank on union investment, support; Trump calls UAW president 'stupid'

    06:19
  • Abortion rights movement in Michigan remains stalwart for Democrats in 2024: McMorrow

    07:20
  • 'He needs to listen to us': Gaza ceasefire activists make statement in Michigan Democratic primary

    05:16
  • Joy: They are letting literal Nazis into their den of Trump worship

    11:25

Matthew Herper: Remdivisir is 'a reason for hope, but it's not definitive'

09:18

Matthew Herper: Remdivisir is ‘a reason for hope, but it's not definitive’ Stat News senior reporter Matthew Herper and Boston University Assoc. Prof. of Medicine and Infectious Diseases Dr. Nahid Bhadelia discuss the experimental drug for coronavirus showing remarkable results in an ongoing clinical trial.